alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 10.19.1



THIRD AMENDMENT TO EMPLOYMENT AGREEMENT



This Third Amendment to Employment Agreement (the Third Amendment) is made and entered into as of August 20,
2003 by and between Unified Western Grocers, Inc., a California corporation (the Company) and Alfred A. Plamann (the  Executive).



WHEREAS, the Company and Executive entered into an Employment Agreement (the Employment Agreement), as of February 5, 1996, a copy of which
is attached as Exhibit A, and further entered into the Amendment to Employment Agreement, as of August, 1999 and Second Amendment to Employment Agreement, as of April, 2001, a copy of which are attached as Exhibit B. The
Employment Agreement and the amendments are sometimes referred to as the Amended Employment Agreement; and



WHEREAS, the Company and Executive desire to amend the terms and conditions of the Amended Employment Agreement, as set forth in this Third Amendment.



NOW, THEREFORE, in consideration of the foregoing and of the
mutual covenants herein contained, it is agreed as follows:



A. The Amended Employment Agreement is amended as follows:



1. Subsequent 9(j) is amended and restated to read as follows:



(j) ESPP II. If the Executive incurs a termination of employment with the Company within one
year of a Change of Control, as provided for in (vi) of subsection 8(a) above, then the Executive shall be credited with an additional five years of service for purposes of calculating the Executives benefits under the Unified Western Grocers,
Inc. Executive Salary Protection Plan II (the ESPP II). The Executives benefits under ESPP II shall otherwise be calculated and paid pursuant to the terms of such plan.



(k) Forfeiture. Notwithstanding the foregoing, any right of the Executive to receive the termination
payment, additional years of service under the ESPP II, and benefits hereunder shall be forfeited to the extent of any amounts payable after any breach of Section 10 by the Executive.



B. Except as amended by this Third Amendment, the terms and conditions of the
Amended Employment Agreement remain in effect.



1



---

IN WITNESS WHEREOF, the parties hereto have executed this Third Amendment as of the day and year first
above written.



|Company:                      |  |                                                     |  |  |  | Executive:
|----------------------------- |  | --------------------------------------------------- |  |  |  | ----------
|                              |  |                                                    
|UNIFIED WESTERN GROCERS, INC. |  |                                                     |  | 
|                              |  |                                                     |  | 
|By:                           |  | /s/    EDMUND KEVIN DAVIS                           |  |  |  |           
|                              |  |                                                     |  |  |  |           
|                              |  | Edmund Kevin Davis Chairman,
Compensation Committee |  |  |  |           



2
Exhibit 4.4

   

  
    
      Pursuant to Instruction 4(a) as to Exhibits of Form 20-F, certain identified information
        (marked by [***]) has been excluded from the exhibit because it is both not material and is the type that the registrant treats as private or confidential.

       

    First Amendment to the

    Research and Development Collaboration and License Agreement

     

    This is the first Amendment (hereinafter “Amendment”) to the Research and Development Collaboration and License Agreement between Bayer Pharma AG, a company formed under the laws of Germany, having a
      place of business at Muellerstrasse 178, 13353 Berlin, Germany (hereinafter: “BAYER”) and Compugen Ltd, a company formed under the laws of Israel, having a place of business at 72 Pinchas Rosen Street, Tel Aviv 69512, Israel (hereinafter: “Compugen”)
      effective as of 5 August 2013 (hereinafter: the “Agreement”).

     

    WHEREAS             The parties wish to amend the exhibit specifying the Bayer Development Process.

     

    NOW THEREFORE IT IS AGREED AS FOLLOWS:

     

    
      	1.	The parties agree to replace Exhibit 1.3 of the Agreement by Exhibit 1.3 attached to this Amendment, describing the “Bayer Development Process”.


    

     

    
      	2.	This Amendment shall become retroactively effective as of 5 August 2013.


    

     

    
      	3.	All capitalized terms used herein shall have the meaning set forth in the Agreement. Except as expressly amended pursuant to this Amendment, all other terms and conditions of
              the Agreement shall remain in force unchanged and apply to this Amendment.


    

     

    
      

       

    

    
      
        
 

    

     

    	
            SIGNED for and on behalf of

            Bayer Pharma AG

          	
            SIGNED for and on behalf of

            Compugen Ltd

          
	 	 
	
            Date: February 3, 2014

          	
            Date: February 5, 2014

          
	 	 
	
            
              /s/ Dr. Karl Ziegelbauer

            

            
              Dr. Karl Ziegelbauer

              (Head GDD - TRG Oncology / Gynecological Therapy)

            

          	
            /s/ Anat Cohen-Dayag

            President and CEO

          
	 	 
	
            
              
                /s/ Dr. Bertolt Kreft

              

              Dr. Bertolt Kreft

              (Head GDD-ONC/GT-IABDC)

            

          	 


    
       

      
        2

        
          
 

      

    

     

    Exhibit 1.3: Bayer Development Process

    

    

    [***, 3 pages]

       

    
       

      3
IN THE SUPREME COURT OF PENNSYLVANIA

In the Matter of : No. 1 44 DB 2023 (No. 76 RST 2023)

:

CAROLYN ANN GARNEAU : Attorney Registration No. 31 0608

:

PETITION FOR REINSTATEMENT :

FROM INACTIVE STATUS : ( Lancaster County )

O R D E R

PER CURIAM

AND NOW , this 7 th day of December , 2023, the Report and Recommendation of

Disciplinary Board Member dated November 27 , 2023, is approved and it is ORDERED

that CAROLYN ANN GARNEAU , who has been on Inactive Status, has demonstrated

that s he has the moral qualifications, competency, and learning in law required for

admission to practice in the Commonwealth, shall be and is, hereby reinstated to active

status as a member of the Bar of this Commonwealth. The expenses incurred by the

Board in the i nvestigation and processing of this matter shall be paid by the Petitioner.
# C_2007072EN.01002901.xml

| 29.3.2007 | EN | Official Journal of the European Union | C 72/29 |
| --- | --- | --- | --- |

29.3.2007

EN

Official Journal of the European Union

C 72/29

---

Non-opposition to a notified concentration

(Case COMP/M.4547 — KKR/Permira/Prosiebensat.1)

(Text with EEA relevance)

(2007/C 72/12)

On 22 February 2007, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition website (http://ec.europa.eu/comm/competition/mergers/cases/). This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition website (http://ec.europa.eu/comm/competition/mergers/cases/). This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website under document number 32007M4547. EUR-Lex is the on-line access to European law. (http://eur-lex.europa.eu) |
| --- | --- |

—

in electronic form on the EUR-Lex website under document number 32007M4547. EUR-Lex is the on-line access to European law. (http://eur-lex.europa.eu)

---
```

[Congressional Bills 111th Congress]
[From the U.S. Government Publishing Office]
[H.R. 5382 Introduced in House (IH)]

111th CONGRESS
  2d Session
                                H. R. 5382

 To provide for a temporary freeze on the pay of civilian employees of 
                        the Federal Government.

_______________________________________________________________________

                    IN THE HOUSE OF REPRESENTATIVES

                              May 25, 2010

  Mrs. Bachmann (for herself and Mr. Cantor) introduced the following 
 bill; which was referred to the Committee on Oversight and Government 
                                 Reform

_______________________________________________________________________

                                 A BILL

 
 To provide for a temporary freeze on the pay of civilian employees of 
                        the Federal Government.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. PAY FREEZE.

    (a) In General.--Notwithstanding any other provision of law, for 
purposes of computing compensation for service performed during fiscal 
year 2011 and the first quarter of fiscal year 2012, the rate of salary 
or basic pay for any office or position within the civil service, as 
defined by section 2101 of title 5, United States Code, shall be deemed 
to be equal to the rate of salary or basic pay payable for such office 
or position as of September 30, 2010.
    (b) Rule for New Positions.--For purposes of subsection (a), the 
rate of salary or basic pay payable as of September 30, 2010, for any 
office or position which was not in existence on such date shall be 
deemed to be the rate of salary or basic pay payable to individuals in 
comparable offices or positions on such date.
    (c) Rule of Construction.--Nothing in this section shall be 
considered to apply with respect to any office or position within the 
uniformed services, as defined by section 2101 of title 5, United 
States Code.
                                 <all>
```
<TABLE> <S> <C>

<ARTICLE> 5
       
<S>                                        <C>                     <C>
<PERIOD-TYPE>                              3-MOS                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1997             DEC-31-1996
<PERIOD-END>                               MAR-31-1997             DEC-31-1996
<CASH>                                               0                       0
<SECURITIES>                                         0                       0
<RECEIVABLES>                                        0                       0
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                                     0                       0
<PP&E>                                               0                       0
<DEPRECIATION>                                       0                       0
<TOTAL-ASSETS>                                       0                       0
<CURRENT-LIABILITIES>                           10,496                  10,496
<BONDS>                                              0                       0
<PREFERRED-MANDATORY>                                0                       0
<PREFERRED>                                     24,842<F1>                  24,842<F1>
<COMMON>                                        84,230                  84,230
<OTHER-SE>                                   (119,568)<F2>               (119,568)<F2>
<TOTAL-LIABILITY-AND-EQUITY>                         0                       0
<SALES>                                              0                       0
<TOTAL-REVENUES>                                     0                       0
<CGS>                                                0                       0
<TOTAL-COSTS>                                        0                       0
<OTHER-EXPENSES>                                     0                   9,068
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                       0
<INCOME-PRETAX>                                      0                       0
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                                  0                       0
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                         0                 (9,068)
<EPS-PRIMARY>                                        0                   (.08)
<EPS-DILUTED>                                        0                   (.08)
<FN>
<F1>Contributed Capital
<F2>Retained Eaarnings
</FN>
        



</TABLE>
I 

111TH CONGRESS 

2D SESSION H. R. 5512 

To expand the boundary of Booker T. Washington National Monument, 

and for other purposes. 

IN THE HOUSE OF REPRESENTATIVES 

JUNE 10, 2010 

Mr. PERRIELLO introduced the following bill; which was referred to the 

Committee on Natural Resources 

A BILL 

To expand the boundary of Booker T. Washington National 

Monument, and for other purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Booker T. Washington 

5 Boundary Expansion Act’’. 

6 SEC. 2. BOUNDARY MODIFICATION AND CORRECTIONS. 

7 The Act entitled ‘‘An Act to provide for the establish8 ment of the Booker T. Washington National Monument’’, 

9 approved April 2, 1956 (16 U.S.C. 450ll et seq.) is amend10 ed as follows: 


PWALKER on DSK8KYBLC1PROD with BILLS
2 

HR 5512 IH

1 (1) by striking section 4; 

2 (2) by redesignating section 5 as section 4; 

3 (3) by amending section 4(a), as redesignated 

4 by subsection (b), to read as follows: 

5 ‘‘(a) LANDS ADDED TO MONUMENT.—The boundary 

6 of the Booker T. Washington National Monument is modi7 fied to include— 

8 ‘‘(1) the approximately 15 acres, as generally 

9 depicted on the map entitled ‘Boundary Map, Book10 er T. Washington National Monument, Franklin 

11 County, Virginia’, numbered BOWA 404/80,024, 

12 and dated February 2001; and 

13 ‘‘(2) the approximately 67.5 acres, as generally 

14 depicted on the map entitled ‘llllllll’, 

15 numbered llll and dated lllllll.’’; 

16 (4) by adding after section 4(c), as redesignated 

17 by subsection (b), the following new subsection— 

18 ‘‘(d) AVAILABILITY OF MAPS.—The maps referenced 

19 in subsection (a) shall be on file and available for inspec20 tion in the appropriate offices of the National Park Serv21 ice, Department of the Interior.’’; and 

22 (5) by adding at the end the following new sec23 tion: 


PWALKER on DSK8KYBLC1PROD with BILLS
3 

HR 5512 IH

1 ‘‘SEC. 5. AUTHORIZATION OF APPROPRIATIONS. 

2 ‘‘There are authorized to be appropriated such sums 

3 as may be necessary to carry out the provisions of this 

4 Act.’’. 

Æ 


PWALKER on DSK8KYBLC1PROD with BILLS
```

                                                                    EXHIBIT 32.2

                    CERTIFICATION OF CHIEF FINANCIAL OFFICER
                                   PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

                  In connection with the Quarterly Report of China Mineral
Acquisition Corporation on Form 10-QSB for the quarter period ended September
30, 2004, as filed with the Securities and Exchange Commission (the "Report"),
I, Bing Zhao, Chief Financial Officer and Secretary of China Mineral Acquisition
Corporation, certify, pursuant to 18 U.S.C. Section 1350, as added by Section
906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

                  1. The Report fully complies with the requirements of Section
13(a) or 15(d) of the Securities Exchange Act of 1934; and

                  2. The information contained in the Report fairly presents, in
all material respects, the financial condition and results of operations of the
China Mineral Acquisition Corporation as of and for the period covered by the
Report.

Pursuant to the rules and regulations of the Securities and Exchange Commission,
this certification is being furnished and is not deemed filed.

November 18, 2004                         /s/ Bing Zhao
                                          --------------------------------------
                                          Bing Zhao
                                          Chief Financial Officer and Secretary
```
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

          - [Docket No. 2004N-0516]

# AGENCY:

Food and Drug Administration, HHS.

# ACTION:

Notice; correction.

# SUMMARY:

                        The Food and Drug Administration is correcting a notice that appeared in the                         **Federal Register**                         of October 24, 2005 (70 FR 61455). The document announced an approval by the Office of Management and Budget. The document was published with an incorrect expiration date for OMB control number 0910-0345. This document corrects that error.                    

# FOR FURTHER INFORMATION CONTACT:

Peggy Robbins, Office of Management Programs (HFA-250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301-827-1223.

# SUPPLEMENTARY INFORMATION:

                    In FR Doc. 05-21157, appearing on page 61455 in the                     **Federal Register**                     of Monday, October 24, 2005, the following correction is made:                

                    1. On page 61455, in the second column, in the                     **SUPPLEMENTARY INFORMATION**                     section, beginning on line 13, the sentence “The approval expires on February 30, 2008.” is corrected to read “The approval expires on February 29, 2008.”                

Dated: October 28, 2005.

Jeffrey Shuren,

Assistant Commissioner for Policy.

[FR Doc. 05-21974 Filed 11-3-05; 8:45 am]

BILLING CODE 4160-01-S
<PAGE>   1
                                                                   EXHIBIT 24.2


                        CONSENT OF INDEPENDENT AUDITORS

We consent to the inclusion in the Form 10-K for the fiscal year ended December
31, 1996 of International Remote Imaging Systems, Inc. ("IRIS"), and to the
incorporation by reference in the Registration Statements on Forms S-8 (File
Nos. 2-77496, 33-10631, 33-82560 and 333-19265) and Form S-3 (File No.
333-02001) of our report dated May 26, 1995, with respect to statements of
income and accumulated deficit and cash flows of StatSpin, Inc. for the year
ended March 31, 1995.

/s/ KPMG Peat Marwick LLP

Boston, Massachusetts
April 11, 1997
Policy Modification: Expansion of the D

COVID-19 Workplace Safety Plan to Include

Use of Administrative Leave for COVID-19

Vaccination

This message is intended for all Department of Labor Federal employees.

Dear Colleagues,

This is to advise you of a modification to the attached guidance originally issued on March 10, 2021, titled, “Expansion of

the DOL COVID-19 Workplace Safety Plan to Include Use of Administrative Leave for COVID-19 Vaccination.” The

policy has been expanded to allow employees to claim administrative leave for a COVID-19 vaccine appointment

retroactive to any date that an employee received the vaccine rather than only vaccines received on or after

February 1, 2021. Use of administrative leave under this revised policy remains subject to the same limits, timekeeping

requirements, and documentation requirements outlined in the original guidance.

Questions regarding this matter may be sent to 

Sincerely,

Sydney T. Rose | Chief Human Capital Officer

Last updated: March 19, 2021

LABORNET
## COURT OF APPEALS SECOND DISTRICT OF TEXAS FORT WORTH NO. 02 - 11 - 00096 - CR NO. 02 - 11 - 00097 - CR NO. 02 - 11 - 00098 - CR NO. 02 - 11 - 00099 - CR JOSHUA AUSTIN RODRIGUEZ APPELLANT

V. THE STATE OF TEXAS STATE

------------ FROM THE 432ND DISTRICT COURT OF TARRANT COUNTY

------------ 

### MEMORANDUM OPINION 1

------------ Appellant Joshua Austin Rodriguez appe als his four prison sentence s imposed for engaging in organized criminal activity . We affirm. Appellant pled guilty to five charges of engaging in organized criminal activity an d elected to have a jury decide his punishment. The jury assessed

1 See Tex. R. App. P. 47.4.2

punishment at twenty

- five years’ confinement on four of the charges and recommended ten years ’ probation on the fifth

. 2 The trial court sentenced Appellant to twenty

- five years ’ confinement for the four cases on appeal, to run concurrently

. Appellant’s court

- appointed appellate counsel has filed a mo tion to withdraw as counsel , accompanied by a br ief in support of that motion. In the brief, counsel states , that in his professional opinion the se appeal s are frivolous and without merit. Counsel’s brief and motion meet the requirements of Anders v. Cal ifornia , 386 U.S. 738, 87 S. Ct. 1396 (1967) , by presenting a professional evaluation of the record s demonstrating why there are no arguable grounds for relief. We gave Appellant the opportunity to file a pro se response to the Anders brief , but he has not filed one. The State also has not filed a brief. Once an appellant’s court

- appointed attorney files a motion to withdraw on the grounds that an appeal is frivolous and fulfills the requirements of Anders , this court is obligated to undertake an independent examination of the record. See Stafford v. State , 813 S.W.2d 503, 511 (Tex. Crim. App. 1991); Mays v. State , 904 S.W.2d 920, 922

– 23 (Tex. App.

— Fort Worth 1995, no pet.)

. Only then may we grant counsel’s motion to withdraw. See Penson v. O hio , 488 U.S. 75, 82

– 83, 109 S. Ct. 346, 351 (1988).

2 Appellant did not appeal the case in which he received a probated sentence.3

We have carefully reviewed the record s and counsel’s brief. We agree with counsel that the s e appeal s are wholly frivolous and without merit; we find nothing in the record s that might arguably support t he appeal s

. See Bledsoe v. State , 178 S.W.3d 8 24, 827

– 28 (Tex. Crim. App. 2005); see also Meza v. State , 206 S.W.3d 684, 685 n.6 (Tex. Crim. App. 2006). Accordingly, we grant counsel’s motion to withdraw and affirm the trial court’s judgment s

.

PER CURIAM PANEL: GABRIEL , DAUPHINOT, and GARDNER , JJ. DO NOT PUBLISH Tex. R. App. P. 47.2(b) DELIVERED: June 21, 2012